JPRN-UMIN000003159
Completed
Phase 2
Autologous peripheral blood stem cell transplantation using MEAM regimen with HAART for refractory and relapsed HIV associated lymphoma: multicentered phase2 clinical trial - Auto PBSCT for refractory and relapsed HIV associated lymphoma (ARL209)
Research fund of Ministry Health, Labour and Welfare for a counter measure against AIDS, Okada group and Tanabe group0 sites18 target enrollmentFebruary 10, 2010
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Refractory and relapsed HIV associated lymphoma
- Sponsor
- Research fund of Ministry Health, Labour and Welfare for a counter measure against AIDS, Okada group and Tanabe group
- Enrollment
- 18
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •heart failure, live dysfunction, renal dysfunction uncontrollable opportunistic infection uncontrollable diabetes uncontrollable HIV infection by HAART
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Autologous peripheral blood stem cell transplantation using Thiotepa, Carboplatin and Etoposide conditioning in patients with relapsed or refractory Medulloblastoma, Primitive neuroectodermal tumor (PNET) and Atypical teratoma and rhabdoid tumor (ATRT)relapsed or refractory Medulloblastoma, Primitive neuroectodermal tumor (PNET) and Atypical teratoma and rhabdoid tumor (ATRT)JPRN-UMIN000026084agoya University Graduate School of Medicine10
Completed
Not Applicable
Autologous peripheral blood stem cell transplantation as consolidation for high risk diffuse large B-cell lymphoma:A phase II studyDiffuse Large B-Cell Lymphoma:IPI high risk group, CR1JPRN-UMIN000012546ishiwaki Municipal Hospital18
Recruiting
Not Applicable
Autologous peripheral blood stem cell transplantation for elderly patients (65-74 years old) with multiple myeloma.multiple myelomaJPRN-UMIN000038905Tokyo-Kita Medical Center20
Not yet recruiting
Not Applicable
Autologous Peripheral Blood Stem Cell Treatment for Myocardial Regeneration in Acute Myocardial InfarctioDiseases of the circulatory systemKCT0006114Seoul National University Hospital105
Completed
Not Applicable
autologous hematopoietic stem cell transplantation followed by reduced intensity allogeneic stem cell transplantation for relatively young patients with multiple myelomamultiple myelomaJPRN-UMIN000002533The university of Tokyo Hospital,department of hematology and oncology20